Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Chemical Society Reviews|February 8, 2012
Drug development: longer-lived proteinsStephan Kontos, Jeffrey A Hubbell
Molecular Pharmaceutics|September 14, 2010
Improving protein pharmacokinetics by engineering erythrocyte affinityStephan Kontos, Jeffrey A Hubbell
Current Opinion in Immunology|July 12, 2015
Engineering antigen-specific immunological toleranceStephan Kontos, Alizée J Grimm, Jeffrey A Hubbell
Biomaterials|September 25, 2010
Engineered aprotinin for improved stability of fibrin biomaterialsKristen M Lorentz, Stephan Kontos, Peter Frey, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Engineering antigens for in situ erythrocyte binding induces T-cell deletionStephan Kontos, Iraklis C Kourtis, Karen Y Dane, et al.
Science Advances|November 25, 2015
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginaseKristen M Lorentz, Stephan Kontos, Giacomo Diaceri, et al.
Scientific Reports|October 30, 2015
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigensAlizée J Grimm, Stephan Kontos, Giacomo Diaceri, et al.
Plos One|April 30, 2013
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceIraklis C Kourtis, Sachiko Hirosue, Alexandre de Titta, et al.
Science Translational Medicine|June 12, 2015
Prescription for a pharmacyteJeffrey A Hubbell
Current Opinion in Biotechnology|October 29, 2003
Materials as morphogenetic guides in tissue engineeringJeffrey A Hubbell
Pageof 27